Eric Floyd is Director of Virpax Pharmaceuticals, Inc.. Currently has a direct ownership of 8,018 shares of VRPX, which is worth approximately $3,768. The most recent transaction as insider was on May 18, 2022, when has been sold 4,479 shares (Common Stock, $0.00001 par value) at a price of $1.36 per share, resulting in proceeds of $6,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.02K
0% 3M change
0% 12M change
Total Value Held $3,768

Eric Floyd Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2022
BUY
Open market or private purchase
$6,091 $1.36 p/Share
4,479 Added 35.84%
8,018 Common Stock, $0.00001...
EF

Eric Floyd

Director
Berwyn, PA

Track Institutional and Insider Activities on VRPX

Follow Virpax Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRPX shares.

Notify only if

Insider Trading

Get notified when an Virpax Pharmaceuticals, Inc. insider buys or sells VRPX shares.

Notify only if

News

Receive news related to Virpax Pharmaceuticals, Inc.

Track Activities on VRPX